Einstein/Montefiore Department of Medicine

Department Faculty

Richard A. Murphy, M.D.

Dr. Richard A. Murphy

Assistant Professor, Department of Medicine (General Internal Medicine)


Professional Interests

My interest is improving the diagnosis and management of infectious diseases among marginalized populations in low-income countries. Specifically my research focuses on:  (1) HIV-infected patients with antiretroviral therapy failure, (2) innovative strategies to improve uptake of HAART among HIV-infected patients with acute OI and (3) the epidemiology and management of drug-resistant and emerging infections in resource-poor contexts.


Selected Publications

  1. Murphy RA, Marconi VC, Gandhi RT, Kuritzkes DR, Sunpath H (2012) Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa. PLoS ONE 7(9): e44793. doi:10.1371/journal.pone.0044793
  2. Murphy RA, Sunpath H, Marconi V, Kurtizkes DR, Nachega, J. Second-line antiretroviral therapy: long-term outcomes in South Africa. J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):158-163.
  3. Julg B, Poole D, Ghebremichael M, Castilla C, Altfeld M, Murphy RA, Walker B. (2012) “Factors Predicting Discordant Virological and Immunological Responses to Antiretroviral Therapy in HIV-1 Clade C Infected Zulu/Xhosa in South Africa.” PLoS ONE 7(2): e31161.
  4. Sunpath H, Warren C, Murphy RA. “Operationalizing Early Antiretroviral Initiation in Patients Presenting with tuberculosis and AIDS in South Africa.” Int J Tuberc Lung Dis. 2012 June
  5. Murphy RA, Ronat  JB, Herard P, Blackwell N, Abgrall S, Anderson DJ. “Multidrug- resistant chronic osteomyelitis complicating war injury in Iraqi civilians.” The Journal of Trauma. 2011
  6. Singh A, Sunpath H, Green TN, Padayachi N, Hiramen K, Lie Y, Anton ED, Murphy RA, Reeves JD, Kuritzkes DR, Ndungʼu T. “Drug Resistance and Viral Tropism in HIV-1 Subtype C-Infected Patients in KwaZulu-Natal, South Africa: Implications for Future Treatment Options.” J Acquir Immune Defic Syndr. 2011 Jun 24.
  7. Murphy RA, Taha B, Smeaton L, H. Sunpath, S. Kapagoda, T. Maphasa, D. Kuritzkes. “Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa.” Int J Tuberc Lung Dis. 2010 Jul;14(7):903-8.
  8. Murphy RA. Letter to the Editor: Establishing the Prevalence of Extended-spectrum Beta-lactamases in East Africa. The Lancet, Volume 375, Issue 9713, Pages 460 - 461, 6 February 2010
  9. Murphy RA, Sunpath H, Lu Z, Chelin C, Losina E, Gordon M , Ross D, Ewusi A, Matthews L, Kuritzkes D, Marconi, M. “Outcomes 24 Weeks After First-line Antiretroviral Therapy Failure and HIV-1 Drug Resistance Testing in South Africa.” AIDS, 2010 April 24; Issue (7 ):1007–1012
  10. Murphy RA, France H, Sunpath H, Gordon M, Marconi V C, Kuritzkes D R, McIntosh, K. "Development of Dual-Class Antiretroviral Drug Resistance in a Child Co-infected with HIV and Tuberculosis: A Case Report from KwaZulu-Natal, South Africa" Journal of Tropical Pediatrics, 2008 Sept 11.
  11. Murphy RA. "The Emerging Crisis of Drug-Resistant Tuberculosis in South Africa: Lessons from New York City" Clinical Infectious Diseases, 2008 Jun 1;46(11):1729-32.
  12. Murphy RA, Sunpath H, Kuritzkes DR, Venter F, Gandhi RT. “Antiretroviral Therapy Associated Toxicities in the Resource-Poor World: The Challenge of a Limited Formulary.” Journal of Infectious Disease, 2007 Dec 1;196 Suppl 3:S449-56.
  13. Murphy RA. “Temporary Health Care, Lasting Power – How Human Rights Advocacy Helped the Citizens of Princeville, North Carolina Take on FEMA.” Human Rights Dialogue 2001; Series 2, Number 6: p.15.

Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.


Montefiore Medical Group
Comprehensive Family Care Center
1621 Eastchester Road
Bronx, NY 10461

Tel: 718.405.8040

Collexis Research Profiles
Einstein Research Profiles (ERP) is one of the innovative technologies to create collaborative bridges within and across the entire bench-to-bedside-to-population spectrum of research. The ERP website has been developed in partnership with Collexis to give investigators easy access to PubMed publications, coauthor networks, information about NIH grants, and research networks.